We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in MyoKardia, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 236 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 237 → 0 (-237)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less capital invested

Capital invested by funds: $7.67B → $0 (-$7.67B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 236

Holders
–
Holders Change
-237
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
236
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.08B
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$747M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$602M
4
BlackRock
BlackRock
New York
-$578M
5
BBA
Baker Bros. Advisors
New York
-$410M
Name Holding Trade Value Shares
Change 		Change in
Stake
ABC
226
Associated Banc-Corp
Wisconsin
– -$5K -34 Closed
EI
227
Ellevest Inc
New York
– -$5K -34 Closed
QCG
228
Quadrant Capital Group
Ohio
– -$3K -25 Closed
OSAM
229
O'Shaughnessy Asset Management
Connecticut
– -$3K -23 Closed
IFAM
230
Institutional & Family Asset Management
Colorado
– -$2K -18 Closed
CWC
231
Carolinas Wealth Consulting
North Carolina
– -$2K -15 Closed
BCA
232
Berman Capital Advisors
Georgia
– -$1K -14 Closed
PFWA
233
Paces Ferry Wealth Advisors
Georgia
– -$2K -14 Closed
GWS
234
Glassman Wealth Services
Virginia
– -$1K -4 Closed
6 7 8 9
10

MYOK Hedge Fund Activity: Q4 2020 in Review

0 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q4 2020, worth a combined $0 — down 100% from $7.67B a quarter earlier.

Sellers outnumbered buyers: 236 funds closed out of MYOK and 0 opened new positions — a net loss of 236 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $1.08B sold.

  • 0 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q4 2020, down from 237 in Q3 2020.
  • Funds reported $0 of MyoKardia, Inc. Common Stock stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new MyoKardia, Inc. Common Stock positions in Q4 2020 and 236 closed out, a net change of -236 holders.
  • The largest MyoKardia, Inc. Common Stock seller in Q4 2020 was Fidelity Investments, an estimated $1.08B sold.

Based on aggregated 13F filings for Q4 2020.